GSK Korea To Disclose Incentives Given To Doctors
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In what could be a move that upsets other pharmaceutical outfits operating in Korea, especially local companies, GSK Korea plans to disclose an entire list of incentives, benefits and other financial support it provided to doctors, hospitals and other medical establishments
You may also be interested in...
Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs
SEOUL - In the latest government action against irregular business deals in the medical sector, South Korea's Fair Trade Commission has imposed penalties amounting to KRW550 million (about $484,282) on the country's four leading general hospitals for receiving "donations" from 14 local and international pharmaceutical firms to fund expansion projects
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).